Iovance Biotherapeutics (IOVA) Valuation Check After Amtagvi Outlook Reaffirmation And Governance Concerns [Yahoo! Finance]
Iovance Biotherapeutics, Inc. (IOVA)
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
iovance.com
Company Research
Source: Yahoo! Finance
Iovance Biotherapeutics (IOVA) is back in focus after the company reaffirmed its expectations for Amtagvi's commercial performance, even as shareholder governance claims and management's decision to avoid a sale keep debate around the stock elevated. See our latest analysis for Iovance Biotherapeutics. Despite reaffirmed expectations for Amtagvi and management's preference to keep Iovance independent, the shares have been under pressure, with a 1-day share price return of 6.72% decline and a 1-year total shareholder return of 61.46% decline. This points to weak momentum and ongoing concern about execution and risk. If this kind of volatility has you looking across the sector, it could be a useful moment to scan other healthcare stocks that might better fit your risk tolerance and time horizon. With Iovance trading at US$2.22 after multi year share price declines, but with management signaling confidence in Amtagvi and its cell therapy platform, is the stock being overly punis
Show less
Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IOVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IOVA alerts
High impacting Iovance Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
IOVA
News
- Iovance Biotherapeutics (IOVA) Is Down 14.9% After Governance Scrutiny And Equity Raise Plan Is Revealed [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Iovance Biotherapeutics, Inc. (IOVA), Nutex Health, Inc. (NUTX), Lantheus Holdings, Inc. (LNTH), and Molina Healthcare, Inc. (MOH)GlobeNewswire
- Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review [Yahoo! Finance]Yahoo! Finance
- Iovance Biotherapeutics: Bright Prospects For 2026 [Seeking Alpha]Seeking Alpha
IOVA
Earnings
- 11/6/25 - Beat
IOVA
Sec Filings
- 1/9/26 - Form 8-K
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- IOVA's page on the SEC website